Search results
AstraZeneca endometrial cancer treatment recommended for EU approval
ShareCast· 7 hours agoAstraZeneca announced on Monday that ‘Imfinzi’, or durvalumab, and ‘Lynparza’, or olaparib, have...
AstraZeneca's COVID prevention drug application gets EU fast-track assessment
Reuters via Yahoo Finance UK· 9 hours ago"The EMA's (European Medicines Agency) Committee for Medicinal Products for Human Use(CHMP) granted...
AstraZeneca posts mixed results from recent Imfinzi trials
ShareCast· 6 days agoAstraZeneca announced contrasting results from two phase three trials involving its immunotherapy...
AstraZeneca disappointed with failure of immunotherapy in early-stage lung cancer
Proactive Financial News· 6 days agoAstraZeneca PLC (LSE:AZN) shared some disappointing news on an advanced lung cancer trial of its...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain type of lung cancer
Reuters· 6 days agoAstraZeneca said on Tuesday its blockbuster cancer drug, Imfinzi, failed to improve disease-free survival in a late-stage trial to treat a type of early-stage lung cancer.
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Zacks via Yahoo Finance UK· 5 days agoData from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy...
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters· 5 days agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung...
Benzinga via Yahoo Finance UK· 6 days agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3...
TOP NEWS: AstraZeneca details mixed findings from cancer drug trials
Morningstar· 6 days agoShares in AstraZeneca rose 0.6% to 12,548.00 pence on Tuesday morning. The Cambridge-based pharmaceutical company said Imfinzi met both its primary and secondary aims in a trial on sufferers of bladder cancer.
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Finance UK· 3 days agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...